These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10951511)
1. Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Schaafsma A; Muskiet FA; Storm H; Hofstede GJ; Pakan I; Van der Veer E Eur J Clin Nutr; 2000 Aug; 54(8):626-31. PubMed ID: 10951511 [TBL] [Abstract][Full Text] [Related]
2. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041 [TBL] [Abstract][Full Text] [Related]
3. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. Bolton-Smith C; McMurdo ME; Paterson CR; Mole PA; Harvey JM; Fenton ST; Prynne CJ; Mishra GD; Shearer MJ J Bone Miner Res; 2007 Apr; 22(4):509-19. PubMed ID: 17243866 [TBL] [Abstract][Full Text] [Related]
4. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511 [TBL] [Abstract][Full Text] [Related]
5. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial. Grimnes G; Joakimsen R; Figenschau Y; Torjesen PA; Almås B; Jorde R Osteoporos Int; 2012 Jan; 23(1):201-11. PubMed ID: 21909730 [TBL] [Abstract][Full Text] [Related]
6. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS). Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604 [TBL] [Abstract][Full Text] [Related]
7. Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial. Holick MF; Lamb JJ; Lerman RH; Konda VR; Darland G; Minich DM; Desai A; Chen TC; Austin M; Kornberg J; Chang JL; Hsi A; Bland JS; Tripp ML J Bone Miner Metab; 2010 May; 28(3):342-50. PubMed ID: 20024591 [TBL] [Abstract][Full Text] [Related]
8. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study. Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969 [TBL] [Abstract][Full Text] [Related]
9. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Dawson-Hughes B; Harris SS; Krall EA; Dallal GE; Falconer G; Green CL Am J Clin Nutr; 1995 May; 61(5):1140-5. PubMed ID: 7733040 [TBL] [Abstract][Full Text] [Related]
10. Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome. Lamb JJ; Holick MF; Lerman RH; Konda VR; Minich DM; Desai A; Chen TC; Austin M; Kornberg J; Chang JL; Hsi A; Bland JS; Tripp ML Nutr Res; 2011 May; 31(5):347-55. PubMed ID: 21636012 [TBL] [Abstract][Full Text] [Related]
11. Oral Vitamin D Supplements Increase Serum 25-Hydroxyvitamin D in Postmenopausal Women and Reduce Bone Calcium Flux Measured by 41Ca Skeletal Labeling. Schild A; Herter-Aeberli I; Fattinger K; Anderegg S; Schulze-König T; Vockenhuber C; Synal HA; Bischoff-Ferrari H; Weber P; von Eckardstein A; Zimmermann MB J Nutr; 2015 Oct; 145(10):2333-40. PubMed ID: 26338885 [TBL] [Abstract][Full Text] [Related]
12. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008 [TBL] [Abstract][Full Text] [Related]
13. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Braam LA; Knapen MH; Geusens P; Brouns F; Hamulyák K; Gerichhausen MJ; Vermeer C Calcif Tissue Int; 2003 Jul; 73(1):21-6. PubMed ID: 14506950 [TBL] [Abstract][Full Text] [Related]
14. Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial. Pop LC; Sukumar D; Schneider SH; Schlussel Y; Stahl T; Gordon C; Wang X; Papathomas TV; Shapses SA Osteoporos Int; 2017 Jan; 28(1):377-388. PubMed ID: 27535752 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation and bone mineral density in early postmenopausal women. Cooper L; Clifton-Bligh PB; Nery ML; Figtree G; Twigg S; Hibbert E; Robinson BG Am J Clin Nutr; 2003 May; 77(5):1324-9. PubMed ID: 12716689 [TBL] [Abstract][Full Text] [Related]
16. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. Storm D; Eslin R; Porter ES; Musgrave K; Vereault D; Patton C; Kessenich C; Mohan S; Chen T; Holick MF; Rosen CJ J Clin Endocrinol Metab; 1998 Nov; 83(11):3817-25. PubMed ID: 9814452 [TBL] [Abstract][Full Text] [Related]
17. Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study. Lappe J; Kunz I; Bendik I; Prudence K; Weber P; Recker R; Heaney RP Eur J Nutr; 2013 Feb; 52(1):203-215. PubMed ID: 22302614 [TBL] [Abstract][Full Text] [Related]
18. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E Osteoporos Int; 2013 Sep; 24(9):2499-507. PubMed ID: 23525894 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. Hunter D; Major P; Arden N; Swaminathan R; Andrew T; MacGregor AJ; Keen R; Snieder H; Spector TD J Bone Miner Res; 2000 Nov; 15(11):2276-83. PubMed ID: 11092410 [TBL] [Abstract][Full Text] [Related]
20. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome. Ferlin A; Selice R; Di Mambro A; Ghezzi M; Di Nisio A; Caretta N; Foresta C Osteoporos Int; 2015 Aug; 26(8):2193-202. PubMed ID: 25963234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]